Skip to main content
. 2020 Nov 20;9(11):1154. doi: 10.3390/antiox9111154

Table 2.

Enrichment pathway analysis results. The table shows results obtained by the FunRich tool. Only pathways related to angiogenesis are reported. For each time point, the percentage of enriched genes, the fold enrichment and the Bonferroni-adjusted p-value are reported. Not significant: fold enrichment p-value ≥ 0.05.

3 h_vs._0 h 6 h_vs._0 h 6 h_vs._3 h
Pathway % Enriched Genes Fold Enrichment p-Value (Bonferroni-Adjusted) % Enriched Genes Fold Enrichment p-Value (Bonferroni-Adjusted) % Enriched Genes Fold Enrichment p-Value (Bonferroni-Adjusted)
Beta1 integrin cell surface interactions 25.4 1.1854 0.0146 26.9 1.2561 1.0167 × 10−7 34.1 1.5901 1.441 × 10−7
EGFR-dependent Endothelin signalling events 24.2 1.1825 0.03440 25.9 1.2690 4.5939 × 10−8 33.6 1.645 1.3314 × 10−8
Endothelins Not significant 26.1 1.26 1.3783 × 10−7 33.6 1.6222 4.1668 × 10−8
HIF-1-alpha transcription factor network Not significant Not significant 5.1 4.8831 8.0756 × 10−8
IGF1 pathway 24.2 1.1838 0.0297 25.9 1.2670 6.044 × 10−8 33.6 1.6424 1.5141 × 10−8
LKB1 signalling events 24.8 1.1964 0.0070 26.5 1.2809 4.0980 × 10−9 33.6 1.6210 4.4347 × 10−8
N-cadherin signalling events Not significant Not significant 8.2 2.0655 0.0252
Nectin adhesion pathway 24.2 1.1801 0.0409 26.0 1.2659 6.6551 × 10−8 34.1 1.6590 4.2976 × 10−9
PDGF receptor signalling network 24.3 1.1851 0.0257 26.06 1.2707 3.2165 × 10−8 33.8 1.6507 8.0949 × 10−9
Posttranslational regulation of adherens junction stability and disassembly Not significant Not significant 7.8 2.1230 0.0235
Proteoglycan syndecan-mediated signalling events 25.3 1.1846 0.0167 27.1 1.2724 7.3776 × 10−9 35.0 1.6389 5.2725 × 10−9
RAC1 signalling pathway Not significant Not significant 7.3 2.2556 0.0113
Regulation of CDC42 activity Not significant 15.2 1.2478 0.0083 22.7 1.8607 1.1663 × 10−7
RhoA signalling pathway Not significant Not significant 7.3 2.2556 0.0113
Signalling events mediated by focal adhesion kinase 24.2 1.1834 0.0317 25.9 1.27 4.0022 × 10−8 33.6 1.6462 1.2483 × 10−8
Signalling events mediated by Hepatocyte Growth Factor Receptor (c-Met) 24.3 1.1851 0.0257 26.0 1.2679 5.0634 × 10−8 33.6 1.6398 1.7211 × 10−8
Signalling events mediated by VEGFR1 and VEGFR2 24.7 1.1855 0.0240 26.1 1.2705 3.0898 × 10−8 33.8 1.6469 9.8334 × 10−9
Stabilization and expansion of the E-cadherin adherens junction Not significant Not significant 9.3 2.1399 0.0025
Syndecan-1-mediated signalling events 24.5 1.1881 0.0178 26.2 1.2721 2.1586 × 10−8 33.6 1.6310 2.6854 × 10−8
VEGF and VEGFR signalling network 24.4 1.1782 0.0455 26.2 1.2655 5.8984 × 10−8 33.8 1.6368 1.6437 × 10−8